Nipro Corporation TSE:8086

Nipro : Notice of Subsidiary Name Change and Transfer of Sales Organization of Vascular Division

Published

Source: MarketScreener





December 15, 2025

Notice of Subsidiary Name Change and Transfer of Sales Organization of Vascular Division

NIPRO CORPORATION (Head office: Settsu，Osaka; President: Tsuyoshi Yamazaki; hereinafter "NIPRO") announces that its consolidated subsidiary, Goodman Co., Ltd. (Head office: Naka, Nagoya, Aichi; President: Tomohisa Handa), will change its company name to Nipro Vascular Corporation effective April 1, 2026 (planned). In conjunction with this change, the Sales Organization of Vascular Division at NIPRO will be transferred to the subsidiary. Details are as follows.

  1. Purpose

    Our group aims to enhance its global presence, accelerate business development, and strengthen competitiveness. The purpose of this name change is to unify the NIPRO brand image in the global market and accelerate the vascular business under the NIPRO name. The transfer of the Sales Organization is part of strengthening an integrated system that accurately reflects feedback from the field into business operations and product development, thereby creating new value as a unified group.

  2. Overview of the Consolidated Subsidiary

    (1) Current Name

    Goodman Co., Ltd.

    (2) New Name

    Nipro Vascular Corporation

    (3) Location

    5F, KDX Nagoya Sakae Building, 4-5-3 Sakae, Naka,

    Nagoya, Aichi, Japan

    (4) President

    Tomohisa Handa

    (5) Effective Date of Name Change

    April 1, 2026 (planned)

  3. Impact on Business Performance

This is an internal group reorganization and will have no impact on consolidated business results.

The NIPRO Group positions the vascular business as one of its next pillars, deepening the development of products and services with innovative technology in all vascular fields. Through product development based on users' viewpoints, aiming at reducing patient burden and improving treatment quality, we aim to provide new value to medical settings and society.

Furthermore, at the NIPRO Group, our ambition is to become a truly global, comprehensive healthcare company-one that delivers meaningful value across the world while staying rooted in WA-gokoro, the Japanese spirit of harmony. This guiding principle reflects our belief in respecting others, acting with integrity, and working



together as one.

This news release is meant to provide information on NIPRO's corporate activities and an overview of our initiatives to not only the press but also our many stakeholders, including shareholders and investors in a fair and timely manner.

The information about NIPRO products and services included in this release is not intended for use in attracting customers or as medical advice.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.